Carrying on CombiMatrix's Chip Business, CustomArray Sets Sights on Sequence-Capture Market
January 25, 2011
Carrying on CombiMatrix's Chip Business, CustomArray Sets Sights on Sequence-Capture Market
CEO Brooke Anderson said that the firm believes its sequence-capture approach will be more flexible and more affordable than offerings by established players in the target enrichment market, like Agilent, Roche NimbleGen, and RainDance.
Full-text access for premium subscribers only.
Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.
New to GenomeWeb? Register here quickly.
Related Stories
- Mizuho Initiates Coverage of Affymetrix with Outperform Rating
August 26, 2011 / GenomeWeb Daily News - Researchers Map CNVs in Children with Developmental Delays
August 15, 2011 / GenomeWeb Daily News - Researchers Pinpoint Mutations, Copy Number Changes in Lymphoma Subtypes
August 2, 2011 / GenomeWeb Daily News - SQI Buying Microarray Firm Scienion for $15.6M, and Stock
July 5, 2011 / GenomeWeb Daily News - Study Finds Array and Sequencing Combo Yields Novel Info on Gene Expression
June 28, 2011 / In Sequence